Riskpilot← Back to searchSign inGet full accessBKG-PHARMA ApS
APSDissolvedCVR 27959350Dyrehavevej 53BForskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 20041 employees
Revenue 2016
DKK -616K
-14% vs 2015
EBITDA margin
100.0%
+14% vs 2015
Equity ratio
-849.9%
Financial strength
Net profit 2016
DKK -18M
-18970% vs 2015
| Revenue | DKK -616K | -14% |
| EBITDA | DKK -616K | +14% |
| Net profit | DKK -18M | -18970% |
| Total assets | DKK 316K | -98% |
| Equity | DKK -2,7M | -118% |
| Employees | 1 | — |
Legal name
BKG-PHARMA ApS
CVR number
27959350
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
8. oktober 2004
Share capital
DKK 1.548.836
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2016-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af en direktør i forening to bestyrelsesmedlemmer eller af den samlede bestyrelse.
Address
Dyrehavevej 53B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 837 | 938 | -28 | -715 | -616 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 837 | 938 | -28 | -715 | -616 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -17.448 |
| EBIT | 837 | 938 | -28 | -715 | -18.065 |
| Net financials | 0 | -5 | -35 | -25 | -111 |
| Profit before tax | 837 | 933 | -63 | -740 | -18.176 |
| Tax | 302 | 142 | 2 | -645 | -151 |
| Net profit | 535 | 792 | -65 | -95 | -18.025 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Total assets | 15.146 | 15.777 | 15.623 | 18.059 | 316 |
| Equity | 13.757 | 14.548 | 14.483 | 15.267 | -2.683 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 992 | 690 | 599 | 2.459 | 2.998 |
| Total debt | 992 | 690 | 599 | 2.459 | 2.998 |
EBITDA margin
-61640600.0%
This company
15.8%
Market median
-390130480% vs market
20122016
Equity ratio
-849.9%
This company
38.2%
Market median
-2325% vs market
20122016
Return on equity
-1802543300.0%
This company
18.4%
Market median
-9796431078% vs market
20122016
Net profit margin
-1802543300.0%
This company
8.1%
Market median
-22253621088% vs market
20122016
Asset turnover
-1.95×
This company
1.12×
Market median
-274% vs market
20122016
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20122016
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CS Founder | Founder | 2004 | — | — |
BK Management | Management | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2006 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BKG HOLDING ApS | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BKG-PHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Schou | Founder | 0 companies |
| Birgit Kjældgaard | Management | 0 companies |
| Morten Stadil | Chairman | 0 companies |
| Jeppe Viggo Christensen | Board of Directors | 0 companies |
| Frank Knudsen | Board of Directors | 0 companies |
| Bo Anders Ljungqvist | Chairman | 0 companies |
| Sten Verland | Board of Directors | 0 companies |
| Rasmus Schmiegelow | Chairman | 0 companies |